News

News Highlights

New IoPPN Dean appointed

Posted on 02/05/2017

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is pleased to announce that Professor Ian Everall has been appointed as IoPPN Executive Dean and will take up his position on 1 September 2017.

Professor Everall is currently Cato Chair of Psychiatry and Head of the Department of Psychiatry at the University of Melbourne. He obtained his MBChB at Leicester University School of Medicine and trained in psychiatry at the Bethlem Royal and Maudsley Hospitals. In 1989 he obtained Membership of the Royal College of Psychiatrists and a MRC Clinical Research Training Fellowship, followed in 1992 by an advanced MRC Clinician Scientist Fellowship in the Department of Neuropathology, Institute of Psychiatry.

He gained his PhD in 1992 and in 1993 was appointed Senior Lecturer at the Institute of Psychiatry and Honorary Consultant Psychiatrist at The Maudsley Hospital. In 1999 he was appointed Professor of Experimental Neuropathology at the Institute of Psychiatry and then in 2004 he became Professor of Psychiatry at the University of California, San Diego. At the end of 2009 Professor Everall took up his current position at the University of Melbourne. He is also Director of Research North Western Mental Health and an Honorary Professorial Fellow at the Florey Institute of Neuroscience and Mental Health. Throughout his career, Professor Everall has been heavily involved in organising psychiatry training programmes for trainee psychiatrists.

Professor Everall has been at the forefront of research into cellular, molecular and genetic changes in the brain in major psychiatric disorders for over 20 years. His area of interest includes psychosis, major depression, bipolar disorder and cognitive impairment, especially when associated with HIV infection and methamphetamine use which is becoming a growing social and psychiatric concern globally. Professor Everall is currently working on research into blood based biomarkers to aid in the diagnosis of psychosis and autism spectrum disorder, and further refining the molecular neuropathology of schizophrenia.

Professor Everall said: ‘I am delighted and honoured to be offered this exciting position and to have the opportunity to work with colleagues at the IoPPN to lead what is undoubtedly the top psychiatric research and education institution globally.’

President and Principal of King’s College London, Professor Edward Bryne, said: ‘We look forward to welcoming Professor Everall, whose outstanding track record and leadership will ensure the IoPPN’s reputation as a world class research and education Institute will go from strength to strength.’

News Highlights:

A Cochrane Review published today finds standardised tobacco packaging may reduce smoking prevalence and the appeal of tobacco, as UK legislation bans the use of branding on all cigarette packets from May 2017.

A chemotherapy drug used to treat brain cancer may increase vulnerability to depression by stopping new brain cells from growing, according to a new King's College London study out today in Translational Psychiatry.